You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Phase II SBIR: Responding to NDM-1- Advancement of a new MBL inhibitor to IND
SBC: VENATORX PHARMACEUTICALS INC Topic: NIAIDDESCRIPTION provided by applicant Multi drug resistance in Enterobacteriaceae is regarded as a healthcare crisis While carbapenems are among the most prescribed antibiotics for infections caused by these organisms carbapenem resistance conferred by zinc based metallo carbapenemases Amber Class B is a growing global health concern that threatens to erode the efficacy of these antibiotics both in th ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Preserving beta-lactam utility vs pathogens producing any class of beta-lactamase
SBC: VENATORX PHARMACEUTICALS INC Topic: NIAIDDESCRIPTION provided by applicant Multi drug resistance in Enterobacteriaceae is regarded as a healthcare crisis This crisis has been further amplified by the recent emergence of the NDM andquot super bug geneandquot a zinc based metallo lactamase Amber Class B in Enterobacteriaceae Members of this family of resistance enzymes are found on promiscuous plasmids with other MDR resistance mechanisms ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Development of a Urine Test for the Early Detection of Liver Cancer
SBC: JBS SCIENCE INC Topic: NCIDESCRIPTION provided by applicant Development of a urine test for the early detection of liver cancer The need to develop an effective method of detecting hepatocellular carcinoma HCC is urgent HCC is the third leading cause of cancer deaths and has a year survival rate of less than If HCC is identified early the survival rate can be as high as The survival rate drops significantly however to as l ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Promoting Responsible Drinking: An Internet-based, Interactive Computer Tailored Intervention
SBC: Pro-Change Behavior Systems, Inc. Topic: NIAAADESCRIPTION provided by applicant Excessive alcohol use is associated with a range of serious and costly health social and economic consequences at the individual and societal level This program of research serves as a venue by which to produce and test an innovative science based and cost effective means to intervene in a private convenient and individualized way with employed adults wh ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Long-Acting G-CSF Analog for Treating ARS
SBC: BOLDER BIOTECHNOLOGY INC Topic: NIAIDDESCRIPTION provided by applicant Development of radiological nuclear medical countermeasures to treat Acute Radiation Syndrome ARS is a high priority research area for NIAID Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure often resulting i death Granulocyte colony stimulating ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
In-Patient Pediatric Gastrojejunal Tube Cleaner Eliminating Surgical Intervention
SBC: ACTUATED MEDICAL, INC. Topic: NICHDDESCRIPTION provided by applicant In this Phase II NIH SBIR Actuated Medical Inc will complete the development of the Pedi GJ ClearTM device for clearing occlusions and restoring patency in situ to pediatric gastrojejunal feeding tubes GJ tubes eliminating the need to surgically replace clogged tubes Public Health Problem Enteral nutrition is provided for patients that have a functioning lower gas ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Responsible Drinking: Internet-based, Interactive Computer Tailored Intervention
SBC: Pro-Change Behavior Systems, Inc. Topic: NIAAADESCRIPTION (provided by applicant): Excessive alcohol use is associated with a range of serious and costly health, social, and economic consequences at the individual and societal level. This program of research serves as a venue by which to produce and test an innovative, science-based, and cost-effective means to intervene in a private, convenient, and individualized way with employed adults wh ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
RAIL reduces variability and concentration of stress hormones in blood sampling
SBC: ACTUATED MEDICAL, INC. Topic: NIADESCRIPTION (provided by applicant): In this Phase II SBIR, Actuated Medical, Inc. (f/k/a Piezo Resonance Innovations, Inc) will complete the development of the Resonance Assisted Insertion Lancet (RAIL ) System to reduce animal pain and stress response during laboratory animal blood sampling. Public Health Problem: Understanding the physiological and biological mechanisms of aging is the focus o ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Defining T cell epitopes in Dengue virus infection
SBC: IMMUNOTOPE, INC. Topic: NIAIDDESCRIPTION (provided by applicant): There is a well-recognized need to develop vaccines that stimulates humoral immunity as well as a potent T cell immunity in order to achieve protection from infection with pathogens. Although numerous investigations arefocused on developing vaccines that induce protective humoral responses, only a few studies are aimed towards developing specific T cell immunit ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Low Cost Laser Diagnostic for CD4+ T Cell Counting
SBC: MBIO DIAGNOSTICS INC Topic: NIAIDDESCRIPTION (provided by applicant): The overall goal of this project is to develop and commercialize a simple cell counter for routine enumeration of CD4 cells for management of HIV-infected individuals. HIV-1 mediated CD4 cell destruction is the centralimmunologic feature of HIV-1 infection. Thus, the CD4 count is a critical measurement in initial disease staging, in monitoring antiretroviral t ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health